Table 2. The effects of DCBEI on the levels of neurotransmitters in hippocampus of APP/PS1 mice.
WT | APP/PS1 | APP/PS1 | ||
DCBEI (mg/kg) | ||||
160 | 320 | |||
Ach (×10-2) (pmoL/mgprot) | 1.7±0.2 | 1.3±0.2# | 2.2±0.4* | 2.1±0.5* |
AChE (×10-2) (nmoL/mgprot) | 6.1±0.9 | 8.2±0.9# | 7.6±0.5 | 7.8±1.2 |
ChAT (×10-2) (pmoL/mgprot) | 2.3±0.2 | 2.4±0.4 | 2.6±0.5 | 5.9±0.6** |
Gln (μmol/mgprot) | 0.5±0.2 | 0.8±0.2# | 0.6±0.1 | 0.7±0.2 |
GABA (×10-3, μmol/mgprot) | 3.1±0.5 | 2.4±0.4# | 4.1±0.7** | 4.5±0.8*** |
iso-Hyd (μg/mgprot) | 657.7±118.2 | 492.8±87.8## | 871.1±139.0*** | 988.8±198.5*** |
5-HT (ng/mgprot) | 114.0±10.6 | 90.1±16.1## | 151.9±22.2*** | 181.4±57.9** |
NA (ng/mgprot) | 3.6±0.5 | 2.4±0.3### | 3.8±0.5** | 4.5±0.7*** |
HIS (ng/mgprot) | 7.1±0.4 | 5.4±0.8## | 9.7±1.4*** | 10.9±1.2*** |
5-HIAA (ng/mgprot) | 9.9±2 | 7.6±1.1# | 15.0±2.1*** | 18.2±5.3** |
All date is expressed as mean ± S.D. (n=10). #P < 0.05, ##P < 0.01 and ###P < 0.001 compared with WT group; *P < 0.05, **P < 0.01 and ***P < 0.001 compared with APP/PS1 group.